AlgoTherapeutix blames a “strong placebo effect” for the mid-stage failure for its pain gel ATX01, but the company still ...

• Glucagon-like peptide 1 receptor agonists (GLP-1) (medicines used to lower blood glucose) probably reduce the risk of death due to any cause but may have little or no death due to a heart attack in ...

Scientists have discovered an antibody treatment that may help prevent both muscle loss and bone density loss in people using ...

A new study found that a drug recently approved to treat type 2 diabetes and kidney disease in patients with additional ...

Despite the established links between inflammation and cancer development, the effects of inflammatory signaling on cancer ...

The RNA inhibitor olpasiran significantly reduces a type of "bad cholesterol" that's associated with a high risk of cardiovascular events, according to results from an analysis by a Mount Sinai ...

The RNA inhibitor olpasiran significantly reduces a type of "bad cholesterol" that's associated with a high risk of ...

Demethylation is controlled by an esterase, PP2A methylesterase (PME-1). We tested two potential LCMT-1 small molecule inhibitors and found that methyl ...

Department of Chemical Synthesis, Biocon Bristol Myers Squibb R&D Centre, Biocon Park, Plot No. 2 & 3, Bommasandra–Jigani Link Road, Bangalore 560 099, India ...

Objective To determine whether new users of proton pump inhibitors (PPIs) are at an increased risk of ... based cohort study using a new-user active comparator design. From 1 January 1990 to 30 April ...

Busà Photography / Getty Images Many people believe that being wealthy means having a nice house, a late-model car, and a summer cottage, but the kind of money possessed by the wealthiest 1% of ...

Perioperative chemotherapy with either S-1 or 5-fluorouracil plus oxaliplatin and docetaxel for locally advanced gastric or gastroesophageal junction adenocarcinoma: A prospective trial and matched ...